F. Van Hoof

1.9k total citations · 1 hit paper
43 papers, 1.4k citations indexed

About

F. Van Hoof is a scholar working on Molecular Biology, Clinical Biochemistry and Physiology. According to data from OpenAlex, F. Van Hoof has authored 43 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Clinical Biochemistry and 10 papers in Physiology. Recurrent topics in F. Van Hoof's work include Metabolism and Genetic Disorders (13 papers), Carbohydrate Chemistry and Synthesis (8 papers) and Glycogen Storage Diseases and Myoclonus (7 papers). F. Van Hoof is often cited by papers focused on Metabolism and Genetic Disorders (13 papers), Carbohydrate Chemistry and Synthesis (8 papers) and Glycogen Storage Diseases and Myoclonus (7 papers). F. Van Hoof collaborates with scholars based in Belgium, United Kingdom and France. F. Van Hoof's co-authors include H G Hers, Jòseph Vamecq, Walter M. Verhue, Edmond de Hoffmann, Greet Van den Berghe, B Lederer, Hers Hg, Th. de Barsy, H. S. A. Sherratt and Louis Hue and has published in prestigious journals such as The Lancet, Circulation and The Science of The Total Environment.

In The Last Decade

F. Van Hoof

43 papers receiving 1.3k citations

Hit Papers

The Abnormalities of Lysosomal Enzymes in Mucopolysacchar... 1968 2026 1987 2006 1968 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Van Hoof Belgium 18 621 503 358 325 253 43 1.4k
F. Huijing United States 19 461 0.7× 257 0.5× 346 1.0× 203 0.6× 139 0.5× 33 1.1k
R. Berger Netherlands 22 672 1.1× 315 0.6× 269 0.8× 572 1.8× 125 0.5× 54 1.3k
June E. Ayling United States 24 665 1.1× 175 0.3× 363 1.0× 394 1.2× 96 0.4× 51 1.4k
Nadine Loreau France 16 797 1.3× 156 0.3× 155 0.4× 156 0.5× 77 0.3× 35 1.5k
J.M. te Koppele Netherlands 22 524 0.8× 68 0.1× 297 0.8× 106 0.3× 223 0.9× 54 1.8k
Harry Boström Sweden 23 420 0.7× 104 0.2× 138 0.4× 59 0.2× 97 0.4× 70 1.4k
Yasuho Nishii Japan 24 630 1.0× 150 0.3× 70 0.2× 57 0.2× 94 0.4× 52 2.0k
Takahito Kondo Japan 22 690 1.1× 153 0.3× 63 0.2× 93 0.3× 49 0.2× 51 1.4k
T Ubuka Japan 17 349 0.6× 192 0.4× 159 0.4× 72 0.2× 75 0.3× 93 1.1k
C G Curtis United Kingdom 22 405 0.7× 222 0.4× 38 0.1× 46 0.1× 75 0.3× 86 1.7k

Countries citing papers authored by F. Van Hoof

Since Specialization
Citations

This map shows the geographic impact of F. Van Hoof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Van Hoof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Van Hoof more than expected).

Fields of papers citing papers by F. Van Hoof

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Van Hoof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Van Hoof. The network helps show where F. Van Hoof may publish in the future.

Co-authorship network of co-authors of F. Van Hoof

This figure shows the co-authorship network connecting the top 25 collaborators of F. Van Hoof. A scholar is included among the top collaborators of F. Van Hoof based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Van Hoof. F. Van Hoof is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hoof, F. Van, et al.. (2019). EP-1691 IORT and stray radiation: comparison of 2 commercial linacs. Radiotherapy and Oncology. 133. S909–S910. 1 indexed citations
2.
Hoof, F. Van. (2012). Polyethylene terephthalate catalyzed by titanium (IV) butoxide. 4 indexed citations
3.
Maldergem, Lionel Van, David Tuerlinckx, Ronald J. A. Wanders, et al.. (2000). Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency and early-onset liver cirrhosis in two siblings. European Journal of Pediatrics. 159(1-2). 108–112. 5 indexed citations
4.
Hoof, F. Van, Marie‐Françoise Vincent, Marie‐Cécile Nassogne, et al.. (1999). Identification of new medium‐chain acylcarnitines present in urine of a patient with medium‐chain acyl‐CoA dehydrogenase deficiency. Journal of Inherited Metabolic Disease. 22(1). 9–18. 12 indexed citations
5.
Sokal, Étienne, Raúl Bustos, F. Van Hoof, & J. B. Otte. (1992). LIVER TRANSPLANTATION FOR HEREDITARY TYROSINEMIA—EARLY TRANSPLANTATION FOLLOWING THE PATIENTʼS STABILIZATION. Transplantation. 54(5). 937–938. 16 indexed citations
6.
Sokal, Étienne, F. Van Hoof, Daniele Alberti, et al.. (1992). Progressive cardiac failure following orthotopic liver transplantation for type IV glycogenosis. European Journal of Pediatrics. 151(3). 200–203. 38 indexed citations
8.
Vamecq, Jòseph, et al.. (1989). Developmental patterns of peroxisomal enzymes in amphibian liver during spontaneous and triiodothyronine-induced metamorphosis. Comparative Biochemistry and Physiology Part B Comparative Biochemistry. 93(2). 477–484. 16 indexed citations
9.
Veitch, Keith, et al.. (1989). Altered acyl-CoA metabolism in riboflavin deficiency. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1006(3). 335–343. 33 indexed citations
10.
Lissens, Willy, M Van Lierde, Walter Foulon, et al.. (1988). Prenatal diagnosis of Hunter syndrome using fetal plasma. Prenatal Diagnosis. 8(1). 59–62. 3 indexed citations
11.
Veitch, Keith, et al.. (1988). Effects of riboflavin deficiency and clofibrate treatment on the five acyl-CoA dehydrogenases in rat liver mitochondria. Biochemical Journal. 254(2). 477–481. 13 indexed citations
12.
Parmentier, G., H. Eyssen, Ronald J. A. Wanders, et al.. (1987). Bile acids in peroxisomal disorders. European Journal of Clinical Investigation. 17(5). 386–390. 25 indexed citations
13.
Vamecq, Jòseph, F. Van Hoof, Philippe Evrard, et al.. (1986). Multiple peroxisomal enzymatic deficiency disorders. A comparative biochemical and morphologic study of Zellweger cerebrohepatorenal syndrome and neonatal adrenoleukodystrophy.. PubMed. 125(3). 524–35. 32 indexed citations
14.
Vamecq, Jòseph, Edmond de Hoffmann, & F. Van Hoof. (1985). The microsomal dicarboxylyl-CoA synthetase. Biochemical Journal. 230(3). 683–693. 80 indexed citations
15.
Hoof, F. Van & Jan Verheyden. (1981). Mutagenic activity in the river meuse in Belgium. The Science of The Total Environment. 20(1). 15–22. 16 indexed citations
16.
Broe, Marc E. De, G. Paulus, Gert A. Verpooten, et al.. (1981). Prospective comparative study of the nephrotoxicity of aminoglycosides in human (abstract). Journal of Antimicrobial Chemotherapy. 8(suppl A). 111–113. 17 indexed citations
17.
Hers, H G & F. Van Hoof. (1969). Lysosomes and mucopolysaccharidoses. Biochemical Journal. 115(5). 34P–36P. 6 indexed citations
18.
Hoof, F. Van & H G Hers. (1968). MUCOPOLYSACCHARIDOSIS BY ABSENCE OF α-FUCOSIDASE. The Lancet. 291(7553). 1198–1198. 113 indexed citations
19.
20.
Hoof, F. Van & H G Hers. (1967). The Subgroups of Type III Glycogenosis. European Journal of Biochemistry. 2(3). 265–270. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026